Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
InnoSEAL III: Heparin Dose and Hemostasis Patch in Transradial CAG
NCT05591872Phase 3Unknown
- Sponsor
- Tabba Heart Institute
- Start
- May 2022
- Primary completion
- Apr 2023
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of heparin in Radial artery occlusion (RAO), sponsored by Tabba Heart Institute. Status: unknown.
02
Drugs
heparin
03
Conditions
Radial artery occlusion (RAO)
Beyond the preview
Go deeper on NCT05591872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05591872.